Event Type
Disclosure
Voluntary
Variant
8-K
. Other Events. Theriva Biologics, Inc. (the “Company”) will be making several presentations to investors over the next several weeks. In connection with the pr
. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Presentation of Theriva Biologics, Inc., dated January 2026 104 Cover Page In